UNIVERSITY PARK, Pa. — Torn ligaments and tendons are the bane of athletes and runners, difficult to heal and often taking months or years of rehab. Currently, the only fix for severe tears is to remove intact ligaments and tendons from another part of a patient’s body, or from a cadaver, and use them to repair a knee or ankle.
This method can be costly and inefficient, according to Spencer Szczesny, Penn State assistant professor of biomedical engineering and orthopaedics and rehabilitation, but the medical field has yet to come up with a better solution. Szczesny will co-lead a four-year, $1.25 million, internationally collaborative study, with researchers from Penn State, Trinity College Dublin, Queen's University Belfast and Dublin City University, to observe normal embryonic tendon and ligament development in chickens and mice and develop a process to replicate them synthetically.
“There is a lot of interest in developing artificial ligament and tendon replacements that integrate biologically into the bone and muscle around them and continue to live on in the body,” Szczesny said. “Our goal is to lay the groundwork by observing chick and mouse development and use that information to genetically engineer a working tendon or ligament implant.”
Earlier soft-tissue development methods, such as scaffold-based tissue engineering, have not worked clinically, Szczesny said. Early attempts in the 1970s and 1980s used synthetic polymer grafts as replacements for torn anterior cruciate ligaments, commonly known as the ACL. However, because the materials lacked the ability to remodel or heal from damage, over time the grafts stretched out, loosened up or produced plastic debris in the body and were taken off the market. Current tissue engineering techniques still utilize polymer scaffolds but also incorporate living cells, which are intended to help form an adaptive biological material around the shape of the manmade scaffold-like structure of plastic fibers.